Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C
NCT00637923Phase 2Completed
- Sponsor
- Romark Laboratories
- Start
- Mar 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatitis C (HCV) comparing Nitazoxanide Arm with Placebo Arm (2 arms). Primary endpoint: Sustained Virologic Response. Started Mar 2008; status: completed.
02
Drugs
nitazoxanide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00637923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637923.